Skip to content

Ketotifen

Histamine-1 Receptor Inhibitor — RESPIRATORY SYSTEM

Also known as: HC 20-511, ketotifen fumarate

OfpFDA approvedATC R06AX17ATC S01GX08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ketotifen is an ofp drug in the Histamine-1 Receptor Inhibitor class catalogued in DrugCentral. It was first approved by the FDA in 1999. Its mechanism of action is classified as Histamine H1 Receptor Antagonists. DrugCentral lists 27 molecular targets, including HRH1, HRH1 and HTR2A. Recorded indications include Allergic conjunctivitis.

  • Approval status: ofp (first approved 1999 by the FDA).
  • Drug class: Histamine-1 Receptor Inhibitor.
  • Mechanism of action: Histamine H1 Receptor Antagonists.
  • Molecular targets: HRH1, HRH1, HTR2A and CHRM5 (27 listed in DrugCentral).
  • Indications: Allergic conjunctivitis.
  • ATC code: R06AX17 (Other antihistamines for systemic use).
  • Molecular formula: C19H19NOS; molecular weight 309.43 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Allergic conjunctivitis

Mechanism & targets

Mechanism of action (MoA)Histamine H1 Receptor Antagonists
Established pharmacologic classHistamine-1 Receptor Inhibitor

Molecular targets (27)

TargetGeneActionActivity
Histamine H1 receptorHRH1unknownKi 9.51
Histamine H1 receptorHRH1antagonistKi 9.51
5-hydroxytryptamine receptor 2AHTR2AunknownKi 8.05
Muscarinic acetylcholine receptor M5CHRM5unknownKi 7.73
5-hydroxytryptamine receptor 2BHTR2BunknownKi 7.54
5-hydroxytryptamine receptor 2CHTR2CunknownKi 7.08
Muscarinic acetylcholine receptor M4CHRM4unknownKi 7.08
Muscarinic acetylcholine receptor M1CHRM1unknownKi 7.02
Muscarinic acetylcholine receptor M3CHRM3unknownKi 6.58
Alpha-2B adrenergic receptorADRA2BunknownKi 6.49
5-hydroxytryptamine receptor 3AHTR3AunknownKi 6.47
Transmembrane protein 97TMEM97unknownKi 6.44
5-hydroxytryptamine receptor 7HTR7unknownKi 6.39
D(1A) dopamine receptorDRD1unknownKi 6.36
Muscarinic acetylcholine receptor M2CHRM2unknownKi 6.36
5-hydroxytryptamine receptor 6HTR6unknownKi 6.28
D(3) dopamine receptorDRD3unknownKi 6.18
Alpha-2A adrenergic receptorADRA2AunknownKi 6.09
5-hydroxytryptamine receptor 1AHTR1AunknownKi 5.84
D(2) dopamine receptorDRD2unknownKi 5.76

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1999-07-02FDA——

ATC classification

ATC codeTherapeutic hierarchy
R06AX17RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Other antihistamines for systemic use
S01GX08SENSORY ORGANS › OPHTHALMOLOGICALS › DECONGESTANTS AND ANTIALLERGICS › Other antiallergics

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Treatment failure1304.1
Urticaria145.8
Anaphylactic reaction138.2
Mast cell activation syndrome137.6
Perfume sensitivity131.2
Mastocytosis117.7
Pruritus80.6
Mechanical urticaria72.1
Muscle tension dysphonia68.3
Angioedema67.6
Dysphoria64.3
Skin reaction59.8

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Ketotifen is on its molecule page.

Molecular formulaC19H19NOS
Molecular weight309.43 g/mol
CAS number34580-13-7
InChIKeyZCVMWBYGMWKGHF-UHFFFAOYSA-N
PubChem CID3827
CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ketotifen used for?

DrugCentral lists the following indications for Ketotifen: Allergic conjunctivitis.

How does Ketotifen work?

Ketotifen is classified as Histamine H1 Receptor Antagonists; its molecular targets in DrugCentral include HRH1, HRH1 (antagonist), HTR2A and CHRM5.

When was Ketotifen first approved?

Ketotifen was first approved by the FDA in 1999.

What drug class does Ketotifen belong to?

Ketotifen is in the Histamine-1 Receptor Inhibitor class.

What is the chemical formula of Ketotifen?

Ketotifen has the molecular formula C19H19NOS and a molecular weight of 309.43 g/mol.

Browse: all drugs starting with K · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1999-07-02
AgencyFDA
Targets27
Indications1
FormulaC19H19NOS
DrugCentral ID1530
Interactive profile